Epithelial‐mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer
Background Head and neck cancer is the sixth most common cancer worldwide, with oral squamous cell carcinoma (OSCC) being the most representative type. OSCC is a public health problem with high morbidity and poor survival rate. Epithelial‐mesenchymal transition is emerging as a hallmark in OSCC. Met...
Saved in:
Published in: | Head & neck Vol. 40; no. 10; pp. 2304 - 2313 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken, USA
John Wiley & Sons, Inc
01-10-2018
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Head and neck cancer is the sixth most common cancer worldwide, with oral squamous cell carcinoma (OSCC) being the most representative type. OSCC is a public health problem with high morbidity and poor survival rate. Epithelial‐mesenchymal transition is emerging as a hallmark in OSCC.
Methods
In this study, we described the role of microRNAs in epithelial‐mesenchymal transition regulation in OSCC based on a PubMed search using articles published in English between January 1, 2010, and January 31, 2018.
Results
MicroRNA's regulatory networks seem to be a hallmark of epithelial‐mesenchymal transition in OSCC pathophysiology becoming a growing challenge to design new studies and strategies from biology to clinical applications.
Conclusion
Therefore, we propose that targeting therapies to epithelial‐mesenchymal transition‐type cells, namely, coordinating microRNAs and/or hydrophobic drugs, such as conventional therapy, could be a promising strategy to improve the outcomes of patients with OSCC. |
---|---|
Bibliography: | Section Editor: Robert L. Ferris, MD, PhD |
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/hed.25381 |